Bio-Rad Laboratories Class B
BIO.B
5 hedge funds and large institutions have $4.07M invested in Bio-Rad Laboratories Class B in 2015 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.03% less ownership
Funds ownership: 0.61% → 0.59% (-0.03%)
11% less capital invested
Capital invested by funds: $4.58M → $4.07M (-$514K)
17% less funds holding
Funds holding: 6 → 5 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$15.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Spark Investment Management
New York
|
-$205K |
| 2 |
Citigroup
New York
|
-$2.72K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $2.96M | – | – | – |
|
2
Dimensional Fund Advisors
Austin,
Texas
| $957K | – | – | – |
|
3
UBS Group
Zurich,
Switzerland
| $133K | – | – | – |
|
|
4
Barclays
London,
United Kingdom
| $16K | +$15.8K | +110 | +1,222% |
|
|
5
Citigroup
New York
| $1K | -$2.72K | -19 | -76% |
|
|
SIM
6
Spark Investment Management
New York
| – | -$205K | -1,400 | Closed |
|
BIO.B Hedge Fund Activity: Q3 2015 in Review
5 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q3 2015, worth a combined $4.07M — down 11% from $4.58M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BIO.B and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Barclays, adding an estimated $15.8K. The largest seller was Spark Investment Management, exiting entirely with an estimated $205K sold.
- 5 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q3 2015, down from 6 in Q2 2015.
- Funds reported $4.07M of Bio-Rad Laboratories Class B stock for Q3 2015, down 11% quarter-over-quarter.
- 0 funds opened new Bio-Rad Laboratories Class B positions in Q3 2015 and 1 closed out, a net change of -1 holder.
- The largest Bio-Rad Laboratories Class B buyer in Q3 2015 was Barclays, an estimated $15.8K added.
- The largest Bio-Rad Laboratories Class B seller in Q3 2015 was Spark Investment Management, an estimated $205K sold.
Based on aggregated 13F filings for Q3 2015.